ardisiacrispin b has been researched along with cyclamin in 2 studies
| Studies (ardisiacrispin b) | Trials (ardisiacrispin b) | Recent Studies (post-2010) (ardisiacrispin b) | Studies (cyclamin) | Trials (cyclamin) | Recent Studies (post-2010) (cyclamin) |
|---|---|---|---|---|---|
| 8 | 0 | 2 | 5 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, X; Fushiya, S; Jia, Z; Koike, K; Li, W; Satou, T | 1 |
| He, L; Hui, LP; Koike, K; Li, Q; Li, W; Zhao, CY | 1 |
2 other study(ies) available for ardisiacrispin b and cyclamin
| Article | Year |
|---|---|
Biologically active triterpenoid saponins from Ardisia japonica.
Topics: Antineoplastic Agents, Phytogenic; Ardisia; Drug Screening Assays, Antitumor; Humans; Japan; Nuclear Magnetic Resonance, Biomolecular; Plants, Medicinal; Saponins; Triterpenes | 2007 |
13,28-Epoxy triterpenoid saponins from Ardisia japonica selectively inhibit proliferation of liver cancer cells without affecting normal liver cells.
Topics: Antineoplastic Agents, Phytogenic; Ardisia; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Liver Neoplasms; Molecular Conformation; Saponins; Structure-Activity Relationship; Triterpenes | 2012 |